Drug Trial Radar · NCT07544251
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Last checked: Nov 20, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Apr 20, 2026
Primary completion
Apr 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Integrative Skin Science and ResearchIndustry
- Sponsor type
- Industry
- Collaborators
- Almirall, S.A.
- First posted
- Apr 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.
Conditions
- Acne Vulgaris
Interventions
SarecyclineDrug
One tablet by mouth (weight based dosing at 1.5 mg/kg and rounded to the closest tablet dose at either 60 mg, 100mg, or 150 mg tablet) once a day with food and a full glass of water (about 8 ounces)
DoxycyclineDrug
100 mg twice daily with food and a full glass of water (about 8 ounces)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the relative abundance of tetracycline-resistant bacteria in the gut microbiomeTime frame: From enrollment to the end of treatment at 4 weeks.
- Change in the relative abundance of fungi/yeast in the gut microbiomeTime frame: From enrollment to the end of treatment at 4 weeks.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Integrative Research Institute
Sacramento, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.